Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000765

Drug Information
NameVinorelbine    
SynonymsC'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-; MolPort-006-823-869; CHEMBL607994; methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-acetoxy-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate; CHEBI:480999; UNII-Q6C979R91Y; I06-0084; CID6426842; Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-; DB00361; Vinorelbina [Spanish]; KW 2307 base; Eunades; 71486-22-1; Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12beta,19alpha)-; CID5672; AC1L1KVK; C45H54N4O8; AC1L75Q4; BIDD:PXR0186; ANX-530; NCGC00165966-02; Ambap71486-22-1; CID60780; I06-0085; Vinorelbinum; Navelbine base; Nor-5'-anhydrovinblastine; Vinorelbine ditartrate; vinorelbine; NVB; Vinorelbine Ditartarate; Vinorelbin; KW-2307; Vinorelbine [INN:BAN]; AC1L1TWQ; HSDB 7665; Vinorelbine (INN); methyl (2b,3b,4b,5a,12b,19a)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate; Vinorelbina; CID5311497; Navelbine (TN); Exelbine; MolPort-006-822-661; Vinorelbine tartrate; KW 2307; HMS2090E13; LS-97533; SDP-012; Navelbine; D08680; CID355119; Vinorelbinum [Latin]    
Trade NameNavelbine    
CompanyGlaxoSmithKline    
IndicationCancersApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntineoplastic Agents    
CAS NumberCAS 71486-22-1
FormularC45H54N4O8    
PubChem Compound IDCID 13200033.    
PubChem Substance IDSID 93167204.    
SuperDrug ATC IDL01CA04;    
SuperDrug CAS ID071486221;    
TargetTubulinInhibitor[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Vinca alkaloid and MDR1. Gan To Kagaku Ryoho. 2008 Jul;35(7):1086-9. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543